Skip to main content
    H

    Health Catalyst Inc (HCAT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.37
    -0.01 (-0.72%)

    Market Cap: $105.09M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Health Catalyst Inc (HCAT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Health Catalyst (HCAT) has a market cap of $105.09M and an enterprise value of $51.35M. It kept -74.24% of revenue as net income over the last 12 months. It holds $53.75M more cash than debt, 51.14% of its market cap.

    Total Valuation

    Enterprise value is 51.14% below the market cap, as cash exceeds debt.

    Market Cap$105.09M
    Enterprise Value$51.35M
    Latest price (Nov 17, 2026)$1.37

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.93% in the quarter ended Sep 30, 2026 and grew 11.68% a year over 2 years.

    Shares Outstanding75.39M
    Shares Change (YoY)+7.12%
    Shares Change (QoQ)+1.93%
    Share Count Growth (2Y CAGR)+11.68%

    Valuation Ratios

    Sales and book value multiples are 0.4x and 0.7x. Its year-end P/S ranged from 0.5x to 9.1x from 2019 to 2025.

    P/S Ratio0.4x
    Forward P/S0.4x
    P/B Ratio0.7x
    P/TBV Ratio1.2x
    P/FCF Ratio4.0x
    P/OCF Ratio3.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 1.9x free cash flow.

    EV / Sales0.2x
    EV / FCF1.9x

    Price Statistics

    The stock is down 39.51% over 52 weeks and trades 18.45% below its 50-day average.

    Beta (1Y)1.36
    52-Week Change-39.51%
    1-Month Change-19.88%
    3-Month Change-18.93%
    6-Month Change+7.87%
    5-Year Change-96.79%
    Total Return (1Y)-39.51%
    Total Return (3Y CAGR)-43.97%
    Total Return (5Y CAGR)-51.17%
    Return vs SPY (1Y)-48.43%
    Max Drawdown (1Y)-66.68%
    Max Drawdown (3Y)-91.11%
    Sharpe Ratio (1Y)-0.51
    Correlation with SPY (1Y)0.21
    50-Day Average$1.68
    200-Day Average$1.67
    52-Week Range$0.95 to $3.02
    RSI (14 Days)39.0
    Average Volume (20 Days)353.51K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.70x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.70x
    Quick Ratio1.70x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -138.81% over the last 12 months, against a 5-year average of -37.06%.

    Return on Equity (ROE)-138.81%
    Return on Assets (ROA)-85.12%
    Return on Capital Employed (ROCE)-70.95%
    ROE (5Y Average)-37.06%
    ROA (5Y Average)-19.40%
    ROIC (5Y Average)-22.60%
    Asset Turnover0.66x
    Receivables Turnover6.54x

    Scores

    HCAT has an Altman Z-Score of -8.17, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-8.17
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $272.20M over the last 12 months is down 13.88% from the 12 months before.

    Revenue$272.20M
    Revenue Growth (YoY)-13.88%
    Gross Profit$133.75M
    Operating Income-$178.90M
    Pretax Income-$201.38M
    Net Income-$202.09M
    EBITDA-$66.14M
    EBIT-$113.01M
    Reported EPS (TTM)-$0.06

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 61.32% of the $237.42M in total assets.

    Cash and Equivalents$53.75M
    Total Debt$0
    Net Cash$53.75M
    Net Cash Per Share$0.71
    Working Capital$54.82M
    Shareholder Equity$145.59M
    Book Value Per Share$1.93
    Tangible Book Value$84.41M
    Tangible Book Per Share$1.12
    Total Assets$237.42M
    Total Liabilities$91.83M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.11M of capital spending, operating cash flow left $25.71M of free cash flow.

    Operating Cash Flow$26.82M
    Capital Expenditures$1.11M
    Free Cash Flow$25.71M
    FCF Per Share$0.34
    Depreciation and Amortization$46.91M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -65.72%, against a 5-year average of -45.48%.

    Gross Margin49.13%
    Operating Margin-65.72%
    Pretax Margin-73.98%
    Net Margin-74.24%
    EBITDA Margin-24.30%
    EBIT Margin-41.52%
    FCF Margin9.45%
    Gross Margin (5Y Average)47.21%
    Operating Margin (5Y Average)-45.48%
    Net Margin (5Y Average)-46.57%

    Growth

    Revenue grew 4.05% a year over 3 years.

    Revenue Growth (3Y CAGR)+4.05%
    Revenue Growth (5Y CAGR)+10.50%
    Book Value Per Share Growth (2Y CAGR)-26.36%

    Revenue and profit by year

    Dividends and Yields

    HCAT does not pay a dividend. Its free cash flow yield is 24.89%.

    FCF Yield24.89%
    Buyback Yield-0.58%
    Shareholder Yield-0.58%

    Peer Position

    Against 10 similar companies, HCAT has the 10th highest P/S.

    P/S Ratio0.4x vs 2.1x median
    Revenue Growth (Trailing 4 Quarters, YoY)-13.88% vs +8.59% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -19.50% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-19.50%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HCAT

    What is HCAT's market cap?

    Health Catalyst has a market cap of $105.09M. Its enterprise value, which adds debt and subtracts cash, is $51.35M.

    How many shares of HCAT are outstanding?

    Health Catalyst has 75.39M shares outstanding. The count is up 7.12% from a year earlier.

    Does HCAT pay a dividend?

    No. Health Catalyst does not pay a dividend.

    How much debt does HCAT have?

    Health Catalyst has $0 of total debt and $53.75M of cash and equivalents, a net cash position of $53.75M.